Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: Report of three families: Case report

Naoko Sato, Tomonobu Hasegawa, Naoaki Hori, Maki Fukami, Yasunori Yoshimura, Tsutomu Ogata

研究成果: Article

20 引用 (Scopus)

抄録

Gonadotrophin therapy (GT) is frequently used to induce fertility in Kallmann syndrome (KS). We studied the effects and the consequences of GT in autosomal dominant KS caused by heterozygous FGFR1 mutations. Three Japanese families were examined. In family A, an adult male received GT and had two sons. In family B, an adult female received GT and gave birth to dizygotic male and female twins. In family C, an adult female received GT and produced a son and a daughter. Direct sequencing was performed for FGFR1, and clinical assessment was carried out for KS features. The father and the elder son of family A had P745S mutation, the mother and the female twin of family B had G687R mutation, and the mother and the two children of family C had S107X mutation. KS phenotype was detected for the mutation-positive subjects, except for the elder son of family A who had apparently normal phenotype. GT in FGFR1 mutations is effective in acquiring fertility but has a risk of transmitting the mutation and the disease phenotype to the next generation.

元の言語English
ページ(範囲)2173-2178
ページ数6
ジャーナルHuman Reproduction
20
発行部数8
DOI
出版物ステータスPublished - 2005 8

Fingerprint

Kallmann Syndrome
Receptor, Fibroblast Growth Factor, Type 1
Gonadotropins
Nuclear Family
Mutation
Genes
Therapeutics
Phenotype
Fertility
Mothers
Fathers
Parturition

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

これを引用

Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1 : Report of three families: Case report. / Sato, Naoko; Hasegawa, Tomonobu; Hori, Naoaki; Fukami, Maki; Yoshimura, Yasunori; Ogata, Tsutomu.

:: Human Reproduction, 巻 20, 番号 8, 08.2005, p. 2173-2178.

研究成果: Article

@article{74422ceba96648858340df30c3da8d75,
title = "Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: Report of three families: Case report",
abstract = "Gonadotrophin therapy (GT) is frequently used to induce fertility in Kallmann syndrome (KS). We studied the effects and the consequences of GT in autosomal dominant KS caused by heterozygous FGFR1 mutations. Three Japanese families were examined. In family A, an adult male received GT and had two sons. In family B, an adult female received GT and gave birth to dizygotic male and female twins. In family C, an adult female received GT and produced a son and a daughter. Direct sequencing was performed for FGFR1, and clinical assessment was carried out for KS features. The father and the elder son of family A had P745S mutation, the mother and the female twin of family B had G687R mutation, and the mother and the two children of family C had S107X mutation. KS phenotype was detected for the mutation-positive subjects, except for the elder son of family A who had apparently normal phenotype. GT in FGFR1 mutations is effective in acquiring fertility but has a risk of transmitting the mutation and the disease phenotype to the next generation.",
keywords = "Fertility, FGFR1 mutation, Genetic counselling, Gonadotrophin therapy, Kallmann syndrome",
author = "Naoko Sato and Tomonobu Hasegawa and Naoaki Hori and Maki Fukami and Yasunori Yoshimura and Tsutomu Ogata",
year = "2005",
month = "8",
doi = "10.1093/humrep/dei052",
language = "English",
volume = "20",
pages = "2173--2178",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1

T2 - Report of three families: Case report

AU - Sato, Naoko

AU - Hasegawa, Tomonobu

AU - Hori, Naoaki

AU - Fukami, Maki

AU - Yoshimura, Yasunori

AU - Ogata, Tsutomu

PY - 2005/8

Y1 - 2005/8

N2 - Gonadotrophin therapy (GT) is frequently used to induce fertility in Kallmann syndrome (KS). We studied the effects and the consequences of GT in autosomal dominant KS caused by heterozygous FGFR1 mutations. Three Japanese families were examined. In family A, an adult male received GT and had two sons. In family B, an adult female received GT and gave birth to dizygotic male and female twins. In family C, an adult female received GT and produced a son and a daughter. Direct sequencing was performed for FGFR1, and clinical assessment was carried out for KS features. The father and the elder son of family A had P745S mutation, the mother and the female twin of family B had G687R mutation, and the mother and the two children of family C had S107X mutation. KS phenotype was detected for the mutation-positive subjects, except for the elder son of family A who had apparently normal phenotype. GT in FGFR1 mutations is effective in acquiring fertility but has a risk of transmitting the mutation and the disease phenotype to the next generation.

AB - Gonadotrophin therapy (GT) is frequently used to induce fertility in Kallmann syndrome (KS). We studied the effects and the consequences of GT in autosomal dominant KS caused by heterozygous FGFR1 mutations. Three Japanese families were examined. In family A, an adult male received GT and had two sons. In family B, an adult female received GT and gave birth to dizygotic male and female twins. In family C, an adult female received GT and produced a son and a daughter. Direct sequencing was performed for FGFR1, and clinical assessment was carried out for KS features. The father and the elder son of family A had P745S mutation, the mother and the female twin of family B had G687R mutation, and the mother and the two children of family C had S107X mutation. KS phenotype was detected for the mutation-positive subjects, except for the elder son of family A who had apparently normal phenotype. GT in FGFR1 mutations is effective in acquiring fertility but has a risk of transmitting the mutation and the disease phenotype to the next generation.

KW - Fertility

KW - FGFR1 mutation

KW - Genetic counselling

KW - Gonadotrophin therapy

KW - Kallmann syndrome

UR - http://www.scopus.com/inward/record.url?scp=25144448824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144448824&partnerID=8YFLogxK

U2 - 10.1093/humrep/dei052

DO - 10.1093/humrep/dei052

M3 - Article

C2 - 15845591

AN - SCOPUS:25144448824

VL - 20

SP - 2173

EP - 2178

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 8

ER -